Caring Brands (CABR) Cost of Revenue (2024 - 2025)
Caring Brands' (CABR) quarterly Cost of Revenue came in at $722.0 in Q4 2025, down 65.15% year-on-year from $2072.0 in Q4 2024, and up 147.26% quarter-over-quarter from $292.0 in Q3 2025.
Caring Brands (CABR) Cost of Revenue (2024 - 2025) Analysis & Trends
Caring Brands' Cost of Revenue history runs 2 years deep, the most recent figure standing at $722.0 for Q4 2025.
- On a quarterly basis, Cost of Revenue fell 65.15% year-over-year to $722.0 in Q4 2025; TTM through Dec 2025 was $3764.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1873.0, changed N/A from the prior year.
- Cost of Revenue climbed to $722.0 in Q4 2025 per CABR's latest filing, from $292.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $2072.0 in Q4 2024 and bottomed at $292.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Caring Brands | 20.66 Mn | 18.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 722.00 |
| Dec 31, 2025 | 722.00 |
| Sep 30, 2025 | 292.00 |
| Sep 30, 2025 | 292.00 |
| Mar 31, 2025 | 678.00 |
| Mar 31, 2025 | 678.00 |
| Dec 31, 2024 | 2,072.00 |
| Dec 31, 2024 | 2,072.00 |